These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22228328)

  • 61. Overexpression of CD40 in sacral chordomas and its correlation with low tumor recurrence.
    Li X; Wang S; Chen Y; Liu G; Yang X
    Onkologie; 2013; 36(10):567-71. PubMed ID: 24107910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surgical margins and local control in resection of sacral chordomas.
    Ruggieri P; Angelini A; Ussia G; Montalti M; Mercuri M
    Clin Orthop Relat Res; 2010 Nov; 468(11):2939-47. PubMed ID: 20635173
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of cell-cycle markers in skull base and sacral chordomas.
    Yakkioui Y; Temel Y; Creytens D; Jahanshahi A; Fleischeuer R; Santegoeds RG; Van Overbeeke JJ
    World Neurosurg; 2014; 82(1-2):e311-8. PubMed ID: 23416769
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
    Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
    Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
    Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
    Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.
    Varga PP; Szövérfi Z; Fisher CG; Boriani S; Gokaslan ZL; Dekutoski MB; Chou D; Quraishi NA; Reynolds JJ; Luzzati A; Williams R; Fehlings MG; Germscheid NM; Lazary A; Rhines LD
    Eur Spine J; 2015 May; 24(5):1092-101. PubMed ID: 25533857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survival analysis of patients with spinal chordomas.
    Sun HH; Hong X; Liu B; Cui JQ; Zhou ZM; Xie XH; Wu XT
    Neurosurg Rev; 2019 Jun; 42(2):455-462. PubMed ID: 29732516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Our experience with chordoma treatment].
    Brindza P; Chaloupka R; Grosman R
    Acta Chir Orthop Traumatol Cech; 2009 Oct; 76(5):382-7. PubMed ID: 19912701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. En bloc resection of primary tumors of the cervical spine: report of two cases and systematic review of the literature.
    Cloyd JM; Chou D; Deviren V; Ames CP
    Spine J; 2009 Nov; 9(11):928-35. PubMed ID: 19716772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.
    Akhavan-Sigari R; Gaab MR; Rohde V; Abili M; Ostertag H
    Eur Spine J; 2014 Nov; 23(11):2416-22. PubMed ID: 24929808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.
    von Witzleben A; Goerttler LT; Marienfeld R; Barth H; Lechel A; Mellert K; Böhm M; Kornmann M; Mayer-Steinacker R; von Baer A; Schultheiss M; Flanagan AM; Möller P; Brüderlein S; Barth TF
    Cancer Res; 2015 Sep; 75(18):3823-31. PubMed ID: 26183925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical outcome of recurrent sacral chordoma with further surgical treatment.
    Yang Y; Li Y; Liu W; Xu H; Niu X
    Medicine (Baltimore); 2018 Dec; 97(52):e13730. PubMed ID: 30593146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma.
    Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B
    Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
    Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
    Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
    Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
    World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Base of skull and cervical spine chordomas in children treated by high-dose irradiation.
    Benk V; Liebsch NJ; Munzenrider JE; Efird J; McManus P; Suit H
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):577-81. PubMed ID: 7852123
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.